CXCR2 and cholestasis: Bessho K et al. reported that CXCL8 in the liver serves as a sensitive diagnostic biomarker, and perturbing the CXCL8-CXCR2 signature in the murine model could reduce the course of cholestasis and the risk of biliary obstruction, thereby increasing the overall survival (37).